Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $77.82 USD
Change Today -0.59 / -0.75%
Volume 3.0M
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

medtronic plc (MDT) Snapshot

Open
$78.27
Previous Close
$78.41
Day High
$78.69
Day Low
$77.80
52 Week High
03/25/15 - $79.50
52 Week Low
06/16/14 - $58.32
Market Cap
110.9B
Average Volume 10 Days
4.4M
EPS TTM
$4.00
Shares Outstanding
1.4B
EX-Date
03/26/15
P/E TM
19.5x
Dividend
$1.22
Dividend Yield
1.57%
Current Stock Chart for MEDTRONIC PLC (MDT)

medtronic plc (MDT) Details

Medtronic plc, a healthcare solutions company, provides medical technologies, services, and solutions worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group’s products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group’s products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company also offers a portfolio of surgical, respiratory and monitoring, and vascular therapies solutions, as well as medical supplies. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

49,247 Employees
Last Reported Date: 11/21/14
Founded in 1949

medtronic plc (MDT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.5M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $774.9K
Executive Vice President and Group President ...
Total Annual Compensation: $724.9K
Executive Vice President and Group President ...
Total Annual Compensation: $675.1K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $781.7K
Compensation as of Fiscal Year 2014.

medtronic plc (MDT) Key Developments

Medtronic plc announces Preliminary Revenue Results for the Fourth Quarter Ended April 24, 2015; Provides Adjusted Earnings Per Share Outlook for the Fourth Quarter 2015

Medtronic plc announced preliminary revenue results for the fourth quarter ended April 24, 2015. For the quarter the company reported that revenues surged 60% year-on-year to $7.30 billion. The company announced that it expects fourth quarter 2015 adjusted earnings per share in the upper half of the previously reported range of $1.08 to $1.13 per share versus the $1.03 consensus.

Medtronic Seeks Acquisitions

Medtronic plc (NYSE:MDT) is seeking acquisitions. "We're continuing to make acquisitions as a single company, and at the same pace." Medtronic senior Vice President Stephen Oesterle said.

Medtronic plc Announces FDA Clearance and U.S. Launch of the Euphora Semicompliant Coronary Balloon

Medtronic plc announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora(TM) Semicompliant Balloon Dilatation Catheter, a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buildup. Pre-dilatation with a semicompliant balloon helps physicians determine lesion characteristics, stent selection and facilitates stent access to the lesions - a crucial step for patients with challenging lesions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $77.82 USD -0.59

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $65.48 USD -0.17
Actavis plc $301.35 USD +0.13
Amgen Inc $163.58 USD -0.26
Bristol-Myers Squibb Co $68.30 USD -0.59
GlaxoSmithKline PLC 1,465 GBp +14.00
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 25.0x
Price/Sales 4.4x
Price/Book 3.8x
Price/Cash Flow 31.9x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.